|
Code
|
9627D
|
|
MA number
|
EU/1/17/1247/016
|
|
Product Form:
|
plv iol 1x3 000 IU + 1xsolv.5 ml (liek.inj.skl.+spojené s pomôckou na rekonšt.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Baxalta Innovations GmbH, Austria
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B02 |
ANTIHEMORRHAGICS |
| B02B |
LOCAL HEMOSTATICS, COMBINATIONS |
| B02BD |
Blood coagulation factors |
| B02BD02 |
Coagulation factor VIII |
|
|
Shelf life:
|
24 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intravenous use
|
European Medicines Agency's database
